{
    "clinical_study": {
        "@rank": "67187", 
        "arm_group": [
            {
                "arm_group_label": "hydrochloorthiazide", 
                "arm_group_type": "Active Comparator", 
                "description": "once a day 25 mg"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "once a day placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce\n      hypernatremia and shorten the time of hypernatremia, we investigate the effect of\n      hydrochloorthiazide compared to a placebo"
        }, 
        "brief_title": "Hydrochloorthiazide and Hypernatriaemie", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypernatraemia", 
        "condition_browse": {
            "mesh_term": "Hypernatremia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  sodium > 142\n\n        Exclusion Criteria:\n\n          -  no informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974739", 
            "org_study_id": "ABR 44878"
        }, 
        "intervention": [
            {
                "arm_group_label": "hydrochloorthiazide", 
                "intervention_name": "Hydrochloorthiazide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Diuretics"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "intensive care", 
            "diuretics"
        ], 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leeuwarden", 
                    "country": "Netherlands", 
                    "state": "Friesland", 
                    "zip": "8801 AD"
                }, 
                "name": "Medical Centre Leeuwarden"
            }, 
            "investigator": {
                "last_name": "Christiaan Boerma, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hypernatraemia and Diuretics in Intensive Care Patients", 
        "overall_contact": {
            "email": "matty.koopmans@znb.nl", 
            "last_name": "Matty Koopmans, RN", 
            "phone": "0031582866738", 
            "phone_ext": "6738"
        }, 
        "overall_contact_backup": {
            "email": "christiaan.boerma@znb.nl", 
            "last_name": "Christiaan Boerma, MD", 
            "phone": "0031582866738", 
            "phone_ext": "6738"
        }, 
        "overall_official": {
            "affiliation": "Medical Centre Leeuwarden", 
            "last_name": "Christiaan Boerma, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "a decrease of 5 mmol/L sodium in plama", 
            "measure": "sodium level", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974739"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical Centre Leeuwarden", 
            "investigator_full_name": "E.C. Boerma", 
            "investigator_title": "MD PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "decrease of duration high sodium level in plasma", 
            "measure": "time hypernatraemia", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "source": "Medical Centre Leeuwarden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical Centre Leeuwarden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}